Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$0.29 - $0.89 $1,101 - $3,379
-3,797 Reduced 30.18%
8,786 $2,000
Q2 2022

Aug 15, 2022

BUY
$0.62 - $1.1 $7,801 - $13,841
12,583 New
12,583 $10,000
Q1 2022

May 12, 2022

SELL
$1.07 - $2.71 $17,968 - $45,509
-16,793 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$1.87 - $2.91 $27,419 - $42,669
14,663 Added 688.4%
16,793 $32,000
Q3 2021

Nov 15, 2021

SELL
$3.01 - $4.12 $13,234 - $18,115
-4,397 Reduced 67.37%
2,130 $6,000
Q2 2021

Aug 16, 2021

SELL
$3.62 - $5.23 $50,375 - $72,780
-13,916 Reduced 68.07%
6,527 $26,000
Q1 2021

May 17, 2021

BUY
$3.94 - $8.19 $41,535 - $86,338
10,542 Added 106.47%
20,443 $104,000
Q4 2020

Feb 16, 2021

SELL
$3.99 - $5.7 $51,443 - $73,490
-12,893 Reduced 56.56%
9,901 $40,000
Q3 2020

Nov 16, 2020

BUY
$4.38 - $6.43 $93,307 - $136,978
21,303 Added 1428.77%
22,794 $111,000
Q2 2020

Aug 13, 2020

SELL
$3.0 - $6.9 $7,695 - $17,698
-2,565 Reduced 63.24%
1,491 $8,000
Q1 2020

May 15, 2020

BUY
$2.36 - $9.86 $7,330 - $30,625
3,106 Added 326.95%
4,056 $13,000
Q4 2019

Feb 07, 2020

BUY
$2.69 - $4.92 $2,555 - $4,674
950 New
950 $4,000
Q3 2019

Nov 05, 2019

SELL
$2.59 - $4.16 $655 - $1,052
-253 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$3.6 - $4.78 $27,529 - $36,552
-7,647 Reduced 96.8%
253 $1,000
Q1 2019

May 14, 2019

BUY
$2.62 - $4.44 $822 - $1,394
314 Added 4.14%
7,900 $33,000
Q4 2018

Feb 14, 2019

BUY
$2.28 - $7.15 $14,872 - $46,639
6,523 Added 613.64%
7,586 $19,000
Q3 2018

Nov 13, 2018

SELL
$3.85 - $7.35 $72,753 - $138,892
-18,897 Reduced 94.67%
1,063 $8,000
Q2 2018

Aug 15, 2018

BUY
$3.7 - $5.65 $68,102 - $103,993
18,406 Added 1184.43%
19,960 $73,000
Q1 2018

May 15, 2018

BUY
$3.65 - $5.2 $5,672 - $8,080
1,554 New
1,554 $5,000
Q4 2017

Feb 09, 2018

SELL
$3.4 - $4.15 $22,630 - $27,622
-6,656 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$3.55 - $5.25 $23,628 - $34,944
6,656
6,656 $26,000

About APPLIED GENETIC TECHNOLOGIES CORP


  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.